UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Mather Group LLC.

Mather Group LLC. boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 8.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,403 shares of the healthcare conglomerate’s stock after purchasing an additional 408 shares during the period. Mather Group LLC.’s holdings in UnitedHealth Group were worth $2,673,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Argus Investors Counsel Inc. grew its position in UnitedHealth Group by 2.9% during the fourth quarter. Argus Investors Counsel Inc. now owns 1,662 shares of the healthcare conglomerate’s stock worth $875,000 after buying an additional 47 shares during the period. ABLE Financial Group LLC increased its stake in UnitedHealth Group by 6.5% in the 4th quarter. ABLE Financial Group LLC now owns 2,188 shares of the healthcare conglomerate’s stock valued at $1,152,000 after purchasing an additional 133 shares in the last quarter. Legacy Trust grew its holdings in UnitedHealth Group by 3.0% in the fourth quarter. Legacy Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $450,000 after purchasing an additional 25 shares during the last quarter. Sowell Financial Services LLC raised its stake in shares of UnitedHealth Group by 9.2% during the 4th quarter. Sowell Financial Services LLC now owns 13,429 shares of the healthcare conglomerate’s stock worth $7,070,000 after buying an additional 1,126 shares during the last quarter. Finally, Allworth Financial LP grew its stake in UnitedHealth Group by 0.4% in the 4th quarter. Allworth Financial LP now owns 28,410 shares of the healthcare conglomerate’s stock valued at $14,957,000 after acquiring an additional 127 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.3 %

Shares of NYSE:UNH traded down $1.61 during trading on Tuesday, reaching $568.35. 3,174,019 shares of the stock were exchanged, compared to its average volume of 4,301,054. The firm has a market cap of $523.10 billion, a price-to-earnings ratio of 34.74, a price-to-earnings-growth ratio of 1.64 and a beta of 0.59. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.85 and a current ratio of 0.88. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $591.54. The firm’s 50-day moving average price is $515.96 and its 200 day moving average price is $503.37.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. The business had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $6.14 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, June 17th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 annualized dividend and a dividend yield of 1.48%. UnitedHealth Group’s dividend payout ratio is 51.34%.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. Baird R W upgraded shares of UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. Truist Financial boosted their price target on UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. UBS Group lifted their price objective on UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research report on Thursday, July 18th. TD Cowen raised their price target on shares of UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Finally, Argus upped their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Two analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $614.17.

Insider Buying and Selling at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.